3. EntreMed (ENMD)
Company Profile: EntreMed is a clinical-stage pharmaceutical company working on treatments of cancer and inflammatory diseases.Altman Z-score: -86.84 Current Share Price: $3.80 (June 7) 2011 Return: -27% Current Ratio: 2.90, an indication that EntreMed should be able to meet its short-term liabilities with its current assets.
2. SulphCo (SUF) Company Profile: SulphCo has developed its proprietary Sonocracking technology, which uses ultrasonic sound waves as part of a desulfurization process of crude oil products. Altman Z-score: -115.40 Current Share Price: 6 cents (June 7) 2011 Return: -67% Current Ratio: 0.80, indicating that SulphCo may have trouble meeting its short-term liabilities with its current assets.